Synthesis of the first conjugates of 5-ethynyl-2′-deoxyuridine with closo-dodecaborate and cobalt-bis-dicarbollide boron clusters

被引:23
作者
Semioshkin, Andrey [1 ]
Ilinova, Anna [1 ]
Lobanova, Irina [1 ]
Bregadze, Vladimir [1 ]
Paradowska, Edyta [2 ]
Studzinska, Miroslawa [2 ]
Jablonska, Agnieszka [2 ]
Lesnikowski, Zbigniew J. [2 ]
机构
[1] Russian Acad Sci, AN Nesmeyanov Organoelement Cpds Inst, Moscow 119991, Russia
[2] Polish Acad Sci, Inst Med Biol, Lab Mol Virol & Biol Chem, PL-93232 Lodz, Poland
基金
俄罗斯基础研究基金会;
关键词
5-Ethynyl-2 '-deoxyuridine; Boron cluster conjugates; Closo-dodecaborate; Cobalt-bis-dicarbollide; Oxonium derivatives; Cytotoxicity; NEUTRON-CAPTURE THERAPY; ACID RELATED-COMPOUNDS; OXONIUM DERIVATIVES; NUCLEOSIDE BASES; ADENOSINE; ANALOGS; CELLS; CARBORANES; 5-ALKYNYL; ANION;
D O I
10.1016/j.tet.2013.06.100
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
A new 2'-deoxyuridine modification, 3',5'-bis-(dimethyl-tert-butylsilyl)-5-(3-(2-(dimethylamino)ethoxy)-3-methylbutyn-1-yl)-2'-deoxyuridine was effectively synthesized in four easy steps. Its reactivity toward a range of cyclic oxonium adducts of closo-dodecaborate and cobalt-bis-dicarbollide boron clusters was studied. The cleavage reactions of cluster oxonium rings by the N,N-dimethylamino group of the modified nucleoside led to 5-ethynyl-2'-deoxyuridine conjugates with [B12H12](2-) and [Co(C2B9H11)(2)](-), respectively. Cytotoxicity of these new conjugates in several cell lines was examined. Closo-dodecaborate conjugates showed low cytotoxicity in all examined cell lines, an advantageous and preferred property for potential boron delivering drugs for the boron neutron capture therapy (BNCT) of tumors. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:8034 / 8041
页数:8
相关论文
共 44 条
[11]   Strategies in the design of antiviral drugs [J].
De Clercq, E .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (01) :13-25
[12]   5-Modified-2′-dU and 2′-dC as Mutagenic Anti HIV-1 Proliferation Agents: Synthesis and Activity [J].
El Safadi, Yazan ;
Paillart, Jean-Christophe ;
Laumond, Geraldine ;
Aubertin, Anne-Marie ;
Burger, Alain ;
Marquet, Roland ;
Vivet-Boudou, Valerie .
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (04) :1534-1545
[13]   Carbocyclization reaction of ω-iodo- and 1,ω-diiodo-1-alkynes without the loss of iodine atoms through a carbenoid-chain process [J].
Harada, Toshiro ;
Muramatsu, Keiko ;
Mizunashi, Kenta ;
Kitano, Chie ;
Imaoka, Daisuke ;
Fujiwara, Takayuki ;
Kataoka, Hiroshi .
JOURNAL OF ORGANIC CHEMISTRY, 2008, 73 (01) :249-258
[14]   Synthesis, chemical and enzymatic hydrolysis, and aqueous solubility of amino acid ester prodrugs of 3-carboranyl thymidine analogs for boron neutron capture therapy of brain tumors [J].
Hasabelnaby, Sherifa ;
Goudah, Ayman ;
Agarwal, Hitesh K. ;
Abd Alla, Mosaad S. M. ;
Tjarks, Werner .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 :325-334
[16]   Synthesis and in vitro evaluation of sugar-modified carboranyluridines [J].
Imamura, K ;
Yamamoto, Y .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (15) :1855-1858
[17]  
Kabalka GW, 1996, CANCER NEUTRON CAPTURE THERAPY, P157
[18]   Towards new boron carriers for boron neutron capture therapy:: metallacarboranes and their nucleoside conjugates [J].
Lesnikowski, ZJ ;
Paradowska, E ;
Olejniczak, AB ;
Studzinska, M ;
Seekamp, P ;
Schüssler, U ;
Gabel, D ;
Schinazi, RF ;
Plesek, J .
BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (13) :4168-4175
[19]   Hybridization properties of base-modified oligonucleotides within the double and triple helix motif [J].
Luyten, I ;
Herdewijn, P .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1998, 33 (7-8) :515-576
[20]   Boron and nucleic acid chemistries: merging the best of both worlds [J].
Martin, Anthony R. ;
Vasseur, Jean-Jacques ;
Smietana, Michael .
CHEMICAL SOCIETY REVIEWS, 2013, 42 (13) :5684-5713